National Center for Tuberculosis and Lung Diseases
About National Center for Tuberculosis and Lung Diseases
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at National Center for Tuberculosis and Lung Diseases
During the past decade, National Center for Tuberculosis and Lung Diseases conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4
2005-01-01
2009-03-01
Completed
90
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
2003-08-01
2006-11-01
Completed
86
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)
2003-08-01
2008-07-01
Completed
260
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
2004-10-01
Unknown status
642
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
2007-05-01
2010-08-08
Completed
65
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "National Center for Tuberculosis and Lung Diseases" #1 sponsor was "Fundació Institut Germans Trias i Pujol" with 4 trials, followed by "Global Alliance for TB Drug Development" with 3 trials
sponsored, "Foundation for Innovative New Diagnostics, Switzerland" with 2 trials sponsored, "Emory University" with 1 trials sponsored and "IUATLD, Inc"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Center for Tuberculosis and Lung Diseases"
#1 collaborator was "National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia" with 4 trials as a collaborator, "Epicentre" with 2 trials as a collaborator, "Harvard Medical School (HMS and HSDM)" with 2 trials as a collaborator, "Institute of Tropical Medicine, Belgium" with 2 trials as a collaborator and "Interactive Research and Development" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at National Center for Tuberculosis and Lung Diseases
According to Clinical.Site data, the most researched conditions in "National Center for Tuberculosis and Lung Diseases" are
"Tuberculosis" (6 trials), "Tuberculosis, Multidrug-Resistant" (6 trials), "Tuberculosis, Pulmonary" (4 trials), "Tuberculosis, MDR" (3 trials) and "Close Contacts of Active Tuberculosis" (1 trials). Many other conditions were trialed in "National Center for Tuberculosis and Lung Diseases" in a lesser frequency.
Clinical Trials Intervention Types at National Center for Tuberculosis and Lung Diseases
Most popular intervention types in "National Center for Tuberculosis and Lung Diseases" are "Drug" (8 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bedaquiline" (4 trials), "Moxifloxacin" (4 trials), "Pyrazinamide" (4 trials), "Placebo" (3 trials) and "Clofazimine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at National Center for Tuberculosis and Lung Diseases
The vast majority of trials in "National Center for Tuberculosis and Lung Diseases" are
14 trials for "All" genders.
Clinical Trials Status at National Center for Tuberculosis and Lung Diseases
Currently, there are NaN active trials in "National Center for Tuberculosis and Lung Diseases".
undefined are not yet recruiting,
1 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in National Center for Tuberculosis and Lung Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Center for Tuberculosis and Lung Diseases, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".